Lv62
2780 积分 2025-10-29 加入
List-Mode PET Image Reconstruction Using Deep Image Prior
16天前
已完结
18F-PSMA-1007 PET/CT tumor volume quantification: a game-changing prognostic biomarker for first-line ARPI therapy in metastatic castration-resistant prostate cancer
19天前
已完结
Standardized uptake value-based analysis of two-phase whole-body bone tomoscintigraphies recorded with a high-speed 360° CZT camera in patients with known or suspected inflammatory arthritis
28天前
已完结
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
29天前
已完结
Permissions Share Cite Favorite Original Articles Crossmark: Check for updates Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177 Lu- PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single-center feasibility study
29天前
已完结
The predictive role of [177Lu]Lu-PSMA-617 SPECT/CT semiquantitative parameters from the 1st RLT cycle in advanced mCRPC: a preliminary bicentric lesion-based analysis
29天前
已完结
177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer
29天前
已完结
Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [177Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [68Ga]Ga-PSMA PET
1个月前
已关闭
Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [¹⁷⁷Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [⁶⁸Ga]Ga-PSMA PET
1个月前
已关闭
皖公网安备34019202002308
